Similar medications and substitutes for TRALOKINUMAB-LDRM
In short: Adbry (TRALOKINUMAB-LDRM), also sold under the brand name Adbry, belongs to the Interleukin-13 Antagonist class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Adbry is unsuitable due to side effects, cost, availability, or contraindications.
Switching is a decision to make with your prescriber, not on your own. People most often look for a substitute for one of a few reasons — and the right alternative depends on which one applies:
No alternatives are listed for Adbry in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.